These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin. Duvillié B; Currie C; Chrones T; Bucchini D; Jami J; Joshi RL; Hill DJ Endocrinology; 2002 Apr; 143(4):1530-7. PubMed ID: 11897712 [TBL] [Abstract][Full Text] [Related]
6. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Kulkarni RN; Holzenberger M; Shih DQ; Ozcan U; Stoffel M; Magnuson MA; Kahn CR Nat Genet; 2002 May; 31(1):111-5. PubMed ID: 11923875 [TBL] [Abstract][Full Text] [Related]
7. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. Freund GG; Kulas DT; Way BA; Mooney RA Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537 [TBL] [Abstract][Full Text] [Related]
8. Distinct and overlapping functions of insulin and IGF-I receptors. Nakae J; Kido Y; Accili D Endocr Rev; 2001 Dec; 22(6):818-35. PubMed ID: 11739335 [TBL] [Abstract][Full Text] [Related]
9. Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform. Escribano O; Guillén C; Nevado C; Gómez-Hernández A; Kahn CR; Benito M Diabetes; 2009 Apr; 58(4):820-8. PubMed ID: 19136656 [TBL] [Abstract][Full Text] [Related]
10. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Otani K; Kulkarni RN; Baldwin AC; Krutzfeldt J; Ueki K; Stoffel M; Kahn CR; Polonsky KS Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E41-9. PubMed ID: 14519599 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ Endocrinology; 1999 May; 140(5):2353-63. PubMed ID: 10218989 [TBL] [Abstract][Full Text] [Related]
13. Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing. Da Silva Xavier G; Qian Q; Cullen PJ; Rutter GA Biochem J; 2004 Jan; 377(Pt 1):149-58. PubMed ID: 14563207 [TBL] [Abstract][Full Text] [Related]
14. Insulin receptor isoform A confers a higher proliferative capability to pancreatic beta cells enabling glucose availability and IGF-I signaling. Escribano O; Gómez-Hernández A; Díaz-Castroverde S; Nevado C; García G; Otero YF; Perdomo L; Beneit N; Benito M Mol Cell Endocrinol; 2015 Jul; 409():82-91. PubMed ID: 25797178 [TBL] [Abstract][Full Text] [Related]
15. β-cell insulin receptor deficiency during in utero development induces an islet compensatory overgrowth response. Trinder M; Zhou L; Oakie A; Riopel M; Wang R Oncotarget; 2016 Jul; 7(29):44927-44940. PubMed ID: 27384998 [TBL] [Abstract][Full Text] [Related]
16. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes? Sesti G Ann Med; 2002; 34(6):444-50. PubMed ID: 12523500 [TBL] [Abstract][Full Text] [Related]